An Open-Label Study To Assess The Safety And Efficacy Of Treprostinil To Facilitate Liver Transplantation In Patients With Portopulmonary Hypertension (poph)

被引：0

作者：

Saggar, R. ^{[1
,5
]}

Waxman, A. B. ^{[2
]}

Bartolome, S. ^{[3
]}

Fisher, M. ^{[4
]}

Mcdevitt, S. ^{[5
]}

Zhang, L. ^{[5
]}

Runo, J. ^{[6
]}

Spikes, L. ^{[7
]}

Saggar, R. ^{[1
,5
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA USA

[2] Brigham & Womens Hosp, Boston, MA 02115 USA

[3] UTSW Dallas, Dallas, TX USA

[4] Emory Univ, Atlanta, GA 30322 USA

[5] United Therapeut, Res Triangle Pk, NC USA

[6] Univ Wisconsin, Madison, WI USA

[7] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4797

引用

页数：1

共 50 条

[31] Multicenter, open-label, safety and efficacy study of zonisamide in patients with progressive myoclonic epilepsy
Vossler, DG
NEUROLOGY, 2002, 58 (07) : A296 - A297
[32] Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study
Kawaguchi, Takumi
Komori, Atsumasa
Seike, Masataka
Fujiyama, Shigetoshi
Watanabe, Hiroshi
Tanaka, Masatoshi
Sakisaka, Shotaro
Nakamuta, Makoto
Sasaki, Yutaka
Oketani, Makoto
Hattori, Toshihiro
Katsura, Koichi
Sata, Michio
JOURNAL OF GASTROENTEROLOGY, 2012, 47 (12) : 1342 - 1351
[33] Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study
Takumi Kawaguchi
Atsumasa Komori
Masataka Seike
Shigetoshi Fujiyama
Hiroshi Watanabe
Masatoshi Tanaka
Shotaro Sakisaka
Makoto Nakamuta
Yutaka Sasaki
Makoto Oketani
Toshihiro Hattori
Koichi Katsura
Michio Sata
Journal of Gastroenterology, 2012, 47 : 1342 - 1351
[34] Long-Term Efficacy of Oral Treprostinil in Subjects with Pulmonary Arterial Hypertension: FREEDOM-EV Open-Label Extension Study
White, R. J.
Broderick, M.
Deng, C. Q.
Grover, R.
Holdstock, L.
Khan, A.
Bohns Meyer, G.
Ng, B.
Pulido Zamudio, T.
Saib, I.
Sepulveda, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[35] EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN VERSUS AMLODIPINE IN JAPANESE PATIENTS WITH ESSENTIAL HYPERTENSION: A RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY (PARASOL STUDY)
Yamamoto, Koichi
Yarimizu, Daisuke
Shimanishi, Ayano
Eguchi, Shunsuke
Iekushi, Kazuma
Kario, Kazuomi
Rakugi, Hiromi
JOURNAL OF HYPERTENSION, 2024, 42 (SUPPL 3)
[36] Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
Vallejo, Carlos
Batlle, Montserrat
Vazquez, Lourdes
Solano, Carlos
Sampol, Antonia
Duarte, Rafael
Hernandez, Dolores
Lopez, Javier
Rovira, Montserrat
Jimenez, Santiago
Valcarcel, David
Belloch, Vicente
Jimenez, Monica
Jarque, Isidro
HAEMATOLOGICA, 2014, 99 (10) : 1632 - 1637
[37] The safety and efficacy of oxcarbazepine as adjunctive therapy in children: An open-label study
Mandelbaum, DE
Kugler, SL
Wenger, E
Sachdeo, R
ANNALS OF NEUROLOGY, 1998, 44 (03) : 580 - 580
[38] A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain
Hagen, N. A.
Lapointe, B.
Ong-Lam, M.
Dubuc, B.
Walde, D.
Gagnon, B.
Love, R.
Goel, R.
Hawley, P.
Ngoc, A. Ho
du Souich, P.
CURRENT ONCOLOGY, 2011, 18 (03) : E109 - E116
[39] Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
Gleich, Gerald J.
Roufosse, Florence
Chupp, Geoffrey
Faguer, Stanislas
Walz, Bastian
Reiter, Andreas
Yancey, Steven W.
Bentley, Jane H.
Steinfeld, Jonathan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4431 - +
[40] The safety and efficacy of metformin in fragile X syndrome: An open-label study
Proteau-Lemieux, Melodie
Lacroix, Angelina
Galarneau, Luc
Corbin, Francois
Lepage, Jean-Francois
Caku, Artuela
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 110

← 1 2 3 4 5 →